Skip to main content

Advertisement

SpringerLink
Log in

Migraine and gasdermin D: a new perspective on the inflammatory basis of migraine

  • Original article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Migraine is a common and disabling primary headache disorder and inflammation is a proposed factor in the complex ethiology of the disease. Gasdermin D (GSDMD) is a membrane pore-forming protein acting through the caspase system. End result is cell death caused by leakage of intracellular components to extracellular space which also results in inflammation. Stemming from this knowledge, the potential role of GSDMD in migraine was investigated in this prospective study. This prospective study was conducted between September 2022 to April 2023. 47 patients with migraine were designated as the patient group, whereas 47 healthy volunteers were designated as the control group. Serum GSDMD levels of both groups were compared, with an additional comparison between migraine patients during symptom-free and attack periods. Migraine related characteristics of the patients were also included in the study. Median GSDMD levels of the patient and control group did not reveal a significant difference. Nausea, vomiting and severity of headache were found to be correlated with GSDMD levels in migraine patients. Patients with nausea revealed a higher GSDMD level compared to patients without nausea during both symptom-free and attack periods (p = 0.021 and p = 0.01, respectively). Nausea was correlated to higher GSDMD levels in the patient population during symptom-free period (p = 0.030). The severity of pain was positively correlated with GSDMD levels during the attack period (p < 0.001). Gasdermin family and GSDMD in particular are promising prospects for therapy in a wide spectrum of disorders. Gasdermin proteins are candidates to be the focus for future studies both related to pathogenesis and drug therapy in migraine and varying inflammatory-driven clinical pictures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Burch RC, Buse DC, Lipton RB (2019) Migraine: epidemiology, burden, and comorbidity. Neurol Clin 37(4):631–649

    Article  PubMed  Google Scholar 

  2. Steiner TJ, Stovner LJ, Vos T (2016) GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 17(1):104

    Article  PubMed  PubMed Central  Google Scholar 

  3. Charles A (2018) The pathophysiology of migraine: implications for clinical management. Lancet Neurol 17(2):174–182

    Article  CAS  PubMed  Google Scholar 

  4. Williamson DJ, Hargreaves RJ (2001) Neurogenic inflammation in the context of migraine. Microsc Res Tech 53(3):167–178

    Article  CAS  PubMed  Google Scholar 

  5. Edvinsson L, Haanes KA, Warfvinge K (2019) Does inflammation have a role in migraine? Nat Rev Neurol 15(8):483–490

    Article  PubMed  Google Scholar 

  6. Shi J, Gao W, Shao F (2017) Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci 42(4):245–254

    Article  CAS  PubMed  Google Scholar 

  7. Kesavardhana S, Malireddi RKS, Kanneganti TD (2020) Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol 26(38):567–595

    Article  Google Scholar 

  8. Agosti R (2018) Migraine burden of disease: from the patient’s experience to a socio-economic view. Headache 58(Suppl 1):17–32

    Article  PubMed  Google Scholar 

  9. Yucel A, Thach A, Kumar S, Loden C, Bensink M, Goldfarb N (2020) Estimating the economic burden of migraine on US employers. Am J Manag Care 26(12):e403–e408

    Article  PubMed  Google Scholar 

  10. Hovaguimian A, Roth J (2022) Management of chronic migraine. BMJ 10(379):e067670

    Article  Google Scholar 

  11. Zou J, Zheng Y, Huang Y, Tang D, Kang R, Chen R (2021) The versatile gasdermin family: their function and roles in diseases. Front Immunol 11(12):751533

    Article  Google Scholar 

  12. Hsu SK, Chen YE, Shu ED, Ko CC, Chang WT, Lin IL, Li CY, Gallego RP, Chiu CC (2023) the pyroptotic and nonpyroptotic roles of gasdermins in modulating cancer progression and their perspectives on cancer therapeutics. Arch Immunol Ther Exp (Warsz) 71(1):14

    Article  CAS  PubMed  Google Scholar 

  13. Magnani L, Colantuoni M, Mortellaro A (2022) Gasdermins: new therapeutic targets in host defense, inflammatory diseases, and cancer. Front Immunol 1(13):898298

    Article  Google Scholar 

  14. Humphries F, Shmuel-Galia L, Ketelut-Carneiro N, Li S, Wang B, Nemmara VV, Wilson R, Jiang Z, Khalighinejad F, Muneeruddin K, Shaffer SA, Dutta R, Ionete C, Pesiridis S, Yang S, Thompson PR, Fitzgerald KA (2020) Succination inactivates gasdermin D and blocks pyroptosis. Science 369(6511):1633–1637

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ramachandran R (2018) Neurogenic inflammation and its role in migraine. Semin Immunopathol 40(3):301–314

    Article  CAS  PubMed  Google Scholar 

  16. Erdener ŞE, Kaya Z, Dalkara T (2021) Parenchymal neuroinflammatory signaling and dural neurogenic inflammation in migraine. J Headache Pain 22(1):138

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ferreira KS, Dhillon H, Velly AM (2021) The role of a potential biomarker in patients with migraine: review and new insights. Expert Rev Neurother 21(7):817–831

    Article  CAS  PubMed  Google Scholar 

  18. Chen W, Zhao Y, Dai Y, Nie K (2022) Gastrointestinal inflammation plays a critical role in chemotherapy-induced nausea and vomiting. Eur J Pharmacol 5(936):175379

    Article  Google Scholar 

  19. Vijayan M, Joseph S, James E, Dutta D (2021) A review on radiation induced nausea and vomiting: current management strategies and prominence of radio sensitizers. J Oncol Pharm Pract 27(5):1061–1072

    Article  CAS  PubMed  Google Scholar 

  20. Dennis K, Poon M, Chow E (2015) Nausea and vomiting induced by gastrointestinal radiation therapy: current status and future directions. Curr Opin Support Palliat Care 9(2):182–188

    Article  PubMed  Google Scholar 

  21. Andrews PLR, Cai W, Rudd JA, Sanger GJ (2021) COVID-19, nausea, and vomiting. J Gastroenterol Hepatol 36(3):646–656

    Article  CAS  PubMed  Google Scholar 

  22. Chen CC, Siddiqui FJ, Chen TL, Chan ES, Tam KW (2012) Dexamethasone for prevention of postoperative nausea and vomiting in patients undergoing thyroidectomy: meta-analysis of randomized controlled trials. World J Surg 36(1):61–68

    Article  PubMed  Google Scholar 

  23. Lu H, Zheng C, Liang B, Xiong B (2021) Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis. BMC Cancer 21(1):513

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Togha M, Martami F, Jafari E, Ariyanfar S, Hashemi SM (2022) The prevalence and characteristics of visceral autonomic symptoms among migraineurs: a population-based study. Cephalalgia 42(6):500–509

    Article  PubMed  Google Scholar 

Download references

Funding

Human Gasdermin ELISA kits were provided by Antalya Training and Research Hospital. No additional funding was received.

Author information

Authors and Affiliations

  1. Department of Neurology, Antalya Training and Research Hospital, Antalya, Turkey

    Ruhsen Ocal, Merve Gursoy Hasoglan & Meltem Korucuk

  2. Department of Gastroenterology, Antalya Training and Research Hospital, Antalya, Turkey

    Osman Cagin Buldukoglu & Serkan Ocal

  3. Department of Medical Microbiology, Antalya Training and Research Hospital, Antalya, Turkey

    Yesim Cekin

Authors
  1. Ruhsen Ocal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Osman Cagin Buldukoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Merve Gursoy Hasoglan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Meltem Korucuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yesim Cekin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Serkan Ocal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ruhsen Ocal.

Ethics declarations

Conflict of interest

None of the authors declare any conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ocal, R., Buldukoglu, O.C., Hasoglan, M.G. et al. Migraine and gasdermin D: a new perspective on the inflammatory basis of migraine. Acta Neurol Belg (2024). https://doi.org/10.1007/s13760-024-02523-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13760-024-02523-y

Keywords

Search

Navigation